British Journal of Dermatology

Peroxisome proliferator-activated receptors in cutaneous biology
pp. 229-236(8)
Authors: Kuenzli S.; Saurat J-H.

Minocycline: stain devil?
pp. 237-239(3)
Authors: Good M.L.; Hussey D.L.

Dry environment increases mast cell number and histamine content in dermis in hairless mice
pp. 240-247(8)
Authors: Ashida Y.; Denda M.

Protein oxidative damage in the stratum corneum: evidence for a link between environmental oxidants and the changing prevalence and nature of atopic dermatitis in Japan
pp. 248-254(7)
Authors: Niwa Y.; Sumi H.; Kawahira K.; Terashima T.; Nakamura T.; Akamatsu H.

Immunohistological distribution of the tight junction components ZO-1 and occludin in regenerating human epidermis
pp. 255-260(6)
Authors: Malminen M.; Koivukangas V.; Peltonen J.; Karvonen S-L.; Oikarinen A.; Peltonen S.

Identification of a locus for porokeratosis palmaris et plantaris disseminata to a 6·9-cM region at chromosome 12q24·1–24·2
pp. 261-267(7)
Authors: Wei S.C.; Yang S.; Li M.; Song Y.X.; Zhang X.Q.; Bu L.; Zheng G.Y.; Kong X.Y.; Zhang X.J.

Reciprocal altered expression of T-cadherin and P-cadherin in psoriasis vulgaris
pp. 268-273(6)
Authors: Zhou S.; Matsuyoshi N.; Takeuchi T.; Ohtsuki Y.; Miyachi Y.

Comparison between the expression of basement membrane zone antigens of human interfollicular epidermis and anagen hair follicle using indirect immunofluorescence
pp. 274-281(8)
Authors: Chuang Y.H.; Dean D.; Allen J.; Dawber R.; Wojnarowska F.

Seroreactivity against MAGE-A and LAGE-1 proteins in melanoma patients
pp. 282-288(7)
Authors: Usener D.; Gerhardt A.; Schadendorf D.; Eichmüller S.

Tyrosine phosphate in melanoma progression
pp. 289-295(7)
Authors: Mcardle L.; Bergin O.; Fallowfield M.E.; Dervan P.A.; Easty D.J.

In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity
pp. 296-305(10)
Authors: Gupta A.K.; Kohli Y.

Reproducibility of a four-point clinical severity score for glabellar frown lines
pp. 306-310(5)
Authors: Honeck P.; Weiss C.; Sterry W.; Rzany B.

Provocative use test of nickel coins in nickel-sensitized subjects and controls
pp. 311-317(7)
Authors: Zhai H.; Chew A.-L.; Bashir S.J.; Reagan K.E.; Hostynek J.J.; Maibach H.I.

Sensitivity of the Dermatology Life Quality Index to clinical change in patients with psoriasis
pp. 318-322(5)
Authors: Mazzotti E.; Picardi A.; Sampogna F.; Sera F.; Pasquini P.; Abeni D.

Development of the PSORIQoL, a psoriasis-specific measure of quality of life designed for use in clinical practice and trials
pp. 323-331(9)
Authors: McKenna S.P.; Cook S.A.; Whalley D.; Doward L.C.; Richards H.L.; Griffiths C.E.M.; Van Assche D.

Factors influencing sunless tanning with dihydroxyacetone
pp. 332-340(9)
Authors: Nguyen B.-C.; Kochevar I.E.

Protective and determining factors for the overall lipid peroxidation in ultraviolet A1-irradiated fibroblasts: in vitro and in vivo investigations
pp. 341-349(9)
Authors: Dissemond J.; Schneider L.A.; Brenneisen P.; Briviba K.; Wenk J.; Wlaschek M.; Scharffetter-Kochanek K.

Observer-blind, randomized, intrapatient comparison of a novel 1% coal tar preparation (Exorex) and calcipotriol cream in the treatment of plaque type psoriasis
pp. 350-353(4)
Authors: Tzaneva S.; Hönigsmann H.; Tanew A.

The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial
pp. 354-362(9)
Authors: Berger R.S.; Fu J.L.; Smiles K.A.; Turner C.B.; Schnell B.M.; Werchowski K.M.; Lammers K.M.

Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis
pp. 363-369(7)
Authors: Hoefnagel J.J.; Thio H.B.; Willemze R.; Bouwes Bavinck J.N.

Topical PTH (1–34) is a novel, safe and effective treatment for psoriasis: a randomized self-controlled trial and an open trial
pp. 370-376(7)
Authors: Holick M.F.; Chimeh F.N.; Ray S.

Evaluation of autologous cultured epithelium as replacement skin after tattoo excision: correlation between skin texture and histological features
pp. 377-380(4)
Authors: Kadoya K.; Amano S.; Inomata S.; Tsunenaga M.; Matsuzaki K.; Oshima H.; Tanabe M.; Kumagai N.; Nishiyama T.

Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasis
pp. 381-385(5)
Authors: Hensen P.; Asadullah K.; Windemuth C.; Rüschendorf F.; Hüffmeier U.; Ständer M.; Schmitt-Egenolf M.; Wienker T.F.; Reis A.; Traupe H.

Preoperative monitoring of warfarin in cutaneous surgery
pp. 386-389(4)
Authors: Ah-Weng A.; Natarajan S.; Velangi S.; Langtry J.A.A.

Hyperpigmentation during interferon-alpha therapy for chronic hepatitis C virus infection
pp. 390-394(5)
Authors: Willems M.; Munte K.; Vrolijk J.M.; den Hollander J.C.; Böhm M.; Kemmeren M.H.; de Man R.A.; Brouwer J.T.

A novel p63 sterile alpha motif (SAM) domain mutation in a Japanese patient with ankyloblepharon, ectodermal defects and cleft lip and palate (AEC) syndrome without ankyloblepharon
pp. 395-399(5)
Authors: Tsutsui K.; Asai Y.; Fujimoto A.; Yamamoto M.; Kubo M.; Hatta N.

Subcutaneous nodules on the buttocks as a manifestation of dialysis-related amyloidosis: a clinicopathological entity?
pp. 400-404(5)
Authors: Shimizu S.; Yasui C.; Yasukawa K.; Nakamura H.; Shimizu H.; Tsuchiya K.

A case of galactosialidosis
pp. 405-409(5)
Authors: Nobeyama Y.; Honda M.; Niimura M.

Panniculitis secondary to extravasation of clarithromycin in a patient with 1-antitrypsin deficiency (phenotype PiZ)
pp. 410-413(4)
Authors: Parr D.G.; Stewart D.G.; Hero I.; Stockley R.A.

Pigmentary mosaicism with mosaic chromosome 5p tetrasomy
pp. 414-416(3)
Authors: Hansen L.K.; Brandrup F.; Rasmussen K.

Topical corticosteroid treatment: systemic side-effects
pp. 417-417(1)
Authors: Kane D.; Barnes L.; Fitzgerald O.

Subungual lipoma
pp. 418-418(1)
Authors: Bardazzi F.; Savoia F.; Fanti P.A.

Topical tacrolimus for facial psoriasis
pp. 419-420(2)
Authors: Clayton T.H.; Harrison P.V.; Nicholls R.; Delap M.

Pemphigoid gestationis: maternal sera recognize epitopes restricted to the N-terminal portion of the extracellular domain of BP180 not present on its shed ectodomain
pp. 420-422(3)
Authors: Sitaru C.; Powell J.; Shimanovich I.; Jainta S.; Kirtschig G.; Wojnarowska F.; Zillikens D.

Decreased CGRP staining in alopecia areata
pp. 422-424(3)
Authors: Meyronet D.; Jaber K.; Gentil-Perret A.; Cambazard F.; Misery L.

Milia en plaque: a novel manifestation of chronic cutaneous lupus erythematosus
pp. 424-426(3)
Authors: Kouba D.J.; Owens N.M.; Mimouni D.; Klein W.; Nousari C.H.

Primary cutaneous large cell CD30+ lymphoma in a renal transplant recipient
pp. 426-428(3)
Authors: Cooper S.M.; Turner G.D.H.; Hollowood K.; Gatter K.; Hatton C.; Gray D.; Russell-Jones R.; Wojnarowska F.

Significance of iron status in hair loss in women
pp. 428-428(1)
Authors: Chamberlain A.J.; Dawber R.P.R.

Factors affecting the choice of a ceiling on the number of exposures with TL01 ultraviolet B phototherapy
pp. 428-430(3)
Author: Diffey B.L.

A unique case of sarcoidosis: coexistence of sarcoidal granuloma and histological changes consistent with dermatomyositis
pp. 430-432(3)
Authors: Ito A.; Kazama T.; Ito M.

Exacerbation of psoriasis by thalidomide in Behçet's syndrome
pp. 432-433(2)
Authors: Dobson C.M.; Parslew R.A.

Solitary sclerotic fibroma of the lip
pp. 433-435(3)
Authors: Ide F.; Mishima K.; Saito I.

Eruptive seborrhoeic keratosis in human immunodeficiency virus infection: a coincidence or ‘the sign of Leser-Trélat’?
pp. 435-436(2)
Authors: Inamadar A.C.; Palit A.

Raised limb bands developing in infancy
pp. 436-437(2)
Authors: Russi D.C.; Irvine A.D.; Paller A.S.

A case of disseminated granuloma annulare treated with defibrotide: complete clinical remission and progressive hair darkening
pp. 437-439(3)
Authors: Rubegni P.; Sbano P.; Fimiani M.

The coexistence of cutaneous vasculitis and thrombosis in childhood-onset systemic lupus erythematosus with antiphospholipid antibodies
pp. 439-441(3)
Authors: Tomizawa K.; Sato-Matsumura K.C.; Kajii N.

Radiation therapy as a curative treatment in extraocular sebaceous carcinoma
pp. 441-442(2)
Authors: Conill C.; Toscas I.; Morilla I.; Mascaró J.M.

The first case of sarcoidosis treated with mycophenolate mofetil
pp. 442-442(1)
Author: Altschuler E.L.

Mucocutaneous sarcoidosis treated with mycophenolate mofetil
pp. 442-443(2)
Authors: Kouba D.J.; Mimouni D.; Rencic A.; Nousari C.H.

A novel missense mutation (Gln306His) in exon 7 of the ED1 gene causing anhidrotic ectodermal dysplasia with prominent milia-like facial sebaceous papules
pp. 443-445(3)
Authors: Hsu M.M.L.; Chao S.C.; Lu A.C.H.

Atlas of Clinical Dermatology 3rd edn.
pp. 445-445(1)
Author: Graham-Brown R.

Dermatology: Pocket picture book
pp. 445-445(1)
Author: Bourke J.F.

News and Notices
pp. 445-446(2)